MedPath

Pilot study on Idiopathic intracranial Hypertension: Evaluation of pupillometry as a clinical follow-up parameter

Recruiting
Conditions
G93.2
Benign intracranial hypertension
Registration Number
DRKS00017815
Lead Sponsor
Charité Campus Virchow-KlinikumKlinik für Neurologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Inclusion criteria for patients: 1. patient is able to give informed consent and gives informed consent. 2. Signed informed consent. 3. Age from 18 to 70 years. 4. Diagnostic of idiopathic intracranial hypertension according to Friedman-criteria (Friedman et. al. 2013). 5. Planned lumbar puncture with measuring of the opening pressure. Inclusion criteria for healthy controls: 1. patient is able to give informed consent and gives informed consent. 2. Signed informed consent. 3. Age from 18 to 70 years. 4. no neurological or ophthalmological disease.

Exclusion Criteria

Exclusion criteria for patients: 1. non-corrected refractory anomalies >2,5 dpt res. <-2,5 dpt. 2. Other neuroophthalmological diseases influencing the pupillary light reflex. Exclusion criteria for healthy controls: 1. non-corrected refractory anomalies >2,5 dpt res. <-2,5 dpt. 2. Other neuroophthalmological diseases influencing the pupillary light reflex.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Investigation of the pupillary light reflex in patients with idiopathic intracranial hypertension compared to healthy controls
Secondary Outcome Measures
NameTimeMethod
Investigation of the pupillary light reflex during the course of disease and in relation to clinical measures and findings in the clinical routine. Specifically the relation with the liquor opening pressure and with sonography of the orbita and the brain venes shall be investigated. In addition, quality of life and headache intensity will be measured longitudinally.
© Copyright 2025. All Rights Reserved by MedPath